129 related articles for article (PubMed ID: 17419625)
1. Secretory phospholipase A2 hydrolysis of phospholipid analogues is dependent on water accessibility to the active site.
Peters GH; Møller MS; Jørgensen K; Rönnholm P; Mikkelsen M; Andresen TL
J Am Chem Soc; 2007 May; 129(17):5451-61. PubMed ID: 17419625
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of sn-1 functionalized phospholipids as substrates for secretory phospholipase A2.
Linderoth L; Peters GH; Jørgensen K; Madsen R; Andresen TL
Chem Phys Lipids; 2007 Mar; 146(1):54-66. PubMed ID: 17270166
[TBL] [Abstract][Full Text] [Related]
3. A two-photon view of an enzyme at work: Crotalus atrox venom PLA2 interaction with single-lipid and mixed-lipid giant unilamellar vesicles.
Sanchez SA; Bagatolli LA; Gratton E; Hazlett TL
Biophys J; 2002 Apr; 82(4):2232-43. PubMed ID: 11916878
[TBL] [Abstract][Full Text] [Related]
4. Secretory phospholipase A2 activity toward diverse substrates.
Madsen JJ; Linderoth L; Subramanian AK; Andresen TL; Peters GH
J Phys Chem B; 2011 Jun; 115(21):6853-61. PubMed ID: 21561115
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
[TBL] [Abstract][Full Text] [Related]
6. The size and curvature of anionic covesicle substrate affects the catalytic action of cytosolic phospholipase A2.
Burke JR; Witmer MR; Tredup JA
Arch Biochem Biophys; 1999 May; 365(2):239-47. PubMed ID: 10328818
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic action of phospholipase A₂ on liposomal drug delivery systems.
Hansen AH; Mouritsen OG; Arouri A
Int J Pharm; 2015 Aug; 491(1-2):49-57. PubMed ID: 26056930
[TBL] [Abstract][Full Text] [Related]
8. Water-Intake and Water-Molecule Paths to the Active Site of Secretory Phospholipase A
Tjørnelund HD; Madsen JJ; Peters GHJ
J Phys Chem B; 2020 Mar; 124(10):1881-1891. PubMed ID: 32064878
[TBL] [Abstract][Full Text] [Related]
9. The interaction of phospholipase A2 with phospholipid analogues and inhibitors.
Yu L; Deems RA; Hajdu J; Dennis EA
J Biol Chem; 1990 Feb; 265(5):2657-64. PubMed ID: 2303420
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a regulatory role of cholesterol superlattices in the hydrolytic activity of secretory phospholipase A2 in lipid membranes.
Liu F; Chong PL
Biochemistry; 1999 Mar; 38(13):3867-73. PubMed ID: 10194297
[TBL] [Abstract][Full Text] [Related]
11. Binding of quinacrine to acidic phospholipids and pancreatic phospholipase A2. Effects on the catalytic activity of the enzyme.
Mustonen P; Lehtonen JY; Kinnunen PK
Biochemistry; 1998 Sep; 37(35):12051-7. PubMed ID: 9724516
[TBL] [Abstract][Full Text] [Related]
12. Continuous, vesicle-based fluorimetric assays of 14- and 85-kDa phospholipases A2.
Bayburt T; Yu BZ; Street I; Ghomashchi F; Laliberté F; Perrier H; Wang Z; Homan R; Jain MK; Gelb MH
Anal Biochem; 1995 Nov; 232(1):7-23. PubMed ID: 8600835
[TBL] [Abstract][Full Text] [Related]
13. Theoretical Assessment of Fluorinated Phospholipids in the Design of Liposomal Drug-Delivery Systems.
Madsen JJ; Fristrup P; Peters GH
J Phys Chem B; 2016 Sep; 120(36):9661-71. PubMed ID: 27557037
[TBL] [Abstract][Full Text] [Related]
14. Effects of specific fatty acid acylation of phospholipase A2 on its interfacial binding and catalysis.
Shen Z; Wu SK; Cho W
Biochemistry; 1994 Sep; 33(38):11598-607. PubMed ID: 7918373
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of phospholipase A2 activity toward phospholipids with sn-1 substitutions.
Linderoth L; Andresen TL; Jørgensen K; Madsen R; Peters GH
Biophys J; 2008 Jan; 94(1):14-26. PubMed ID: 17827229
[TBL] [Abstract][Full Text] [Related]
16. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.
Arbibe L; Koumanov K; Vial D; Rougeot C; Faure G; Havet N; Longacre S; Vargaftig BB; Béréziat G; Voelker DR; Wolf C; Touqui L
J Clin Invest; 1998 Sep; 102(6):1152-60. PubMed ID: 9739049
[TBL] [Abstract][Full Text] [Related]
17. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
Leitinger N; Watson AD; Hama SY; Ivandic B; Qiao JH; Huber J; Faull KF; Grass DS; Navab M; Fogelman AM; de Beer FC; Lusis AJ; Berliner JA
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1291-8. PubMed ID: 10323782
[TBL] [Abstract][Full Text] [Related]
18. Halogenated phospholipids regulate secretory phospholipase A2 group IIA activity.
Korotaeva A; Samoilova E; Pavlunina T; Panasenko OM
Chem Phys Lipids; 2013; 167-168():51-6. PubMed ID: 23438648
[TBL] [Abstract][Full Text] [Related]
19. Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI.
Koumanov K; Wolf C; Béreziat G
Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):227-33. PubMed ID: 9337873
[TBL] [Abstract][Full Text] [Related]
20. Use of an imperfect neutral diluent and outer vesicle layer scooting mode hydrolysis to analyze the interfacial kinetics, inhibition, and substrate preferences of bee venom phospholipase A2.
Yu BZ; Ghomashchi F; Cajal Y; Annand RR; Berg OG; Gelb MH; Jain MK
Biochemistry; 1997 Apr; 36(13):3870-81. PubMed ID: 9092817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
